Influence of the alpha-1-adrenergic receptor blocker doxazosin on exercise-induced hyperkalemia in hemodialysis patients

Kidney and Blood Pressure Research

Volumn 25, Issue 1, 2002, Pages 55-60

  Nowicki, Michał ^a,b   Waluś, Tomasz ^b   Kokot, Franciszek ^b  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^b UNIVERSITY OF SILESIA   (Poland)

Author keywords

Adrenergic blockade; Hemodialysis; Hyperkalemia; Physical exercise; Terminal renal failure

Indexed keywords

ALDOSTERONE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; DOXAZOSIN; GLUCOSE; INSULIN; PHOSPHATE; POTASSIUM; PROTON; RENIN; SODIUM;

ADULT; ALDOSTERONE BLOOD LEVEL; ANURIA; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG TOLERANCE; EXERCISE TEST; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HEMODIALYSIS PATIENT; HUMAN; HYPERKALEMIA; INSULIN BLOOD LEVEL; KIDNEY FAILURE; MALE; PHOSPHATE BLOOD LEVEL; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM BLOOD LEVEL; TREADMILL EXERCISE; WORKLOAD;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; CROSS-OVER STUDIES; DOXAZOSIN; EXERCISE; FEMALE; HUMANS; HYPERKALEMIA; MALE; MIDDLE AGED; POTASSIUM; RENAL DIALYSIS; TREATMENT FAILURE;

EID: 0036166654     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000049436     Document Type: Article

References (25)

1. Hyperkalemia: A potential silent killer
2. Variability in potassium removal by hemodialysis
3. Catecholamine modulation of rapid potassium shifts during exercise
4. Adrenergic modulation of potassium metabolism in uremia
5. Extrarenal potassium homeostasis
6. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure
7. + pump in chronic renal failure
8. Hyperkalemia in end-stage renal disease: Mechanisms and management
9. Effect of albuterol treatment on subsequent dialytic potassium removal
10. Prolonged β-adrenergic stimulation: A new way to reduce plasma potassium concentration in hemodialysis patients
11. The use of ACE inhibitors in patients with chronic renal disease - Are there problems?
12. Influence of the renin-angiotensin system stimulation on renal erythropoietin production in patients with various forms of arterial hypertension
13. Potassium regulation during exercise and recovery in humans: Implications for skeletal and cardiac muscle
14. 1-adrenoceptor antagonist: Pharmacokinetics and concentration-effect relationships in man
15. Efficacy and safety of doxazosin in hypertension therapy
16. Pharmacokinetics and effect on blood pressure of doxazosin in normal subjects and patients with renal failure
17. Adrenergic modulation of potassium metabolism during exercise in normal and diabetic humans
18. Enhanced exercise-induced hyperkalemia in patients with syndrome X
19. Impairment of external potassium disposal by α-adrenergic stimulation
20. Adrenergic modulation of extrarenal potassium disposal in men with end-stage renal disease
21. Are calcium antagonists proarrhythmic
22. Albuterol and insulin for treatment of hyperkalemia in HD patients
23. Effects in humans of extracellular pH change in relationship between serum potassium concentration and intracellular potassium
24. The role of aldosterone in potassium tolerance: Studies in anephric humans
25. Glycolysis and pyruvate oxidation